Patents by Inventor Franz Buchegger

Franz Buchegger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies with specificity affinity for human carcinoembryonic antigen
    Patent number: 5047507
    Abstract: The invention concerns novel monoclonal antibodies with high specificity to and affinity for human carcinoembryonic antigen (CEA), derivatives thereof, processes for the preparation of these antibodies and their derivatives, hybridoma cell lines secreting the antibodies, and processes for the preparation of said cell lines. The monoclonal antibodies of the invention and their derivatives are useful in the diagnosis and therapy of cancer and serial monitoring of cancer patients for recurrent disease or response to therapy. Test kits and pharmaceutical compositions containing said monoclonal anti-CEA antibodies are also subject of the invention.
    Type: Grant
    Filed: January 4, 1989
    Date of Patent: September 10, 1991
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Franz Buchegger, Jean-Pierre Mach